EFV
Eva Fortea Verdejo Wells Fargo Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
23
Avg Return
Past Year
Past Year
33%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
36.4%
Neutral
63.6%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Equal-Weight
Maintained
| $25 |
5%
downside
| 3 | – |
–
| 19 Nov ‘25 14 days ago |
|
|
|
Equal-Weight
Maintained
| $11 |
39%
downside
| 1 | -33% |
0
%
| 11 Nov ‘25 22 days ago |
|
|
|
Equal-Weight
Maintained
| $6 |
23%
downside
| 1 | – |
–
| 7 Nov ‘25 26 days ago |
|
|
|
Overweight
Initiated
| $60 |
58%
upside
| 1 | +18% |
0
%
| 31 Oct ‘25 1 month ago |
|
|
|
Overweight
Maintained
| $29 |
13%
upside
| 1 | +49% |
0
%
| 20 Oct ‘25 1 month ago |
|
|
|
Equal-Weight
Downgraded
| $97 |
1%
upside
| 2 | +46% |
0
%
| 30 Sep ‘25 2 months ago |
|
|
|
Overweight
Maintained
| $45 |
11%
upside
| 1 | +23% |
0
%
| 25 Sep ‘25 2 months ago |
|
|
|
Overweight
Maintained
| $70 |
10%
downside
| 1 | +92% |
0
%
| 11 Sep ‘25 2 months ago |
|